All the news


Fund raising

Magnisense raises successfully €5.5 million. New shareholders join the company. Long-standing shareholders take part in the funding round. Additional directors join the Board.


Magnisense participates in the Deauville Women’s Forum

Magnisense, Dassault Systèmes and Roche discuss about the future of health at the Women’s Forum in Deauville, the 14, 15 and 16 of october 2015.



Magnisense receives €1.2 million in financing from Bpifrance for its innovative MI2 project


Le Campus

Magnisense inaugurated January 30, 2015, its new R&D lab named “Le Campus” in presence of BPI France, APHP and actors of innovation and economy


Sandrine Danancher, Directeur commercial France et Suisse | MBA HEC

Sandrine Danancher est directeur commercial France et Suisse. Elle a acquis près de 20 ans d’expérience sur le marché du dispositif médical et du diagnostic in vitro, avec près de 20 ans d’expertise en direction grands comptes, marketing, puis ...


Les Echos

APHP validates the cardiovascular tests developed by Magnisense


Magnisense & AP-HP

Magnisense and AP-HP sign a partnership agreement to develop emergency diagnostic tests for cardio-vascular diseases